The global regenerative medicine market size
is expected to reach USD 5.59 billion by 2025, according to a new report by
Grand View Research, Inc. Increased prevalence of neurodegenerative,
orthopedic, and other aging-related disorders in geriatric population coupled
with rising global geriatric population is anticipated to drive market growth.
Developments in biotechnology
have enabled gaining in-depth knowledge pertaining to cell division and
differentiation as well as the metabolism mechanism of various cells. This
enriched knowledge, coupled with emergence of novel streams of biotechnology
such as gene therapy and nanotechnology, further prospered use of cell-based
technology in therapeutic treatment.
Well established regenerative
approached for various dermatological indications exists since ages.
Technological advances introduced scaffolds, matrices, and grafts engineered
for faster regeneration and minimal surgical procedure.
Identification of ability of stem
cells to develop into various different cell lines further propelled the
advancements in regenerative medicine. Frequent media exposure due to
regulatory as well as ethical controversies around embryonic stem cells has
increased awareness among the masses. This encouraged researchers to explore
and develop other potential fields for similar applications, such as induced
pluripotent stem cells (iPSC).
Furthermore, the emergence of
gene therapy techniques with potential to rectify and restore effects of gene
mutations in cells is under development. Conditions caused due to Single
Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative
characteristics are primarily targeted.
Biologics, individually or in
combination with cells or devices, are explored to support regenerate the
biological functions of cells, tissues, or organs. A number of combinatorial
therapies to support chemotherapy and other cancer treatments by prevention as
well as treatment for cancer relapse are in development phases.
In addition, rising prevalence of
complicated degenerative disorders such as age-related macular degeneration,
Alzheimer’s disease, and Parkinson’s disease, especially in the aging
population resulted in high investments in R&D to develop therapeutic
solutions.
Regenerative medicine grabs the
attention of the healthcare industry owing to its promising applications along
with significant advances in supportive fields including tissue engineering,
stem cells, gene therapy, drug discovery and nanotechnology. For instance, 3D
printing over scaffold with stem cells to restore structure as well as
functional characteristics of biological cells, tissues, and organs.
Browse full research report on Global
Regenerative Medicine Market: http://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market
Further key findings from the report suggest:
- The global regenerative medicine demand exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable rate over the forecast period owing to the presence of a strong looking product pipeline with anticipated commercializations just around the corner
- Therapeutics emerged as the largest product segment in 2016 as it has a relatively high implementation and usage rate resulting in higher adoption
- Global regenerative services demand for facilities such as tissue banks and cellular engineering tools is expected to drive demand in the segment
- The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies with increased focus of dominant players in emerging economies is attributive to market growth. market.
- Key players including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and MiMedx are involved in complex technical cum financial partnerships with larger players in an attempt to expedite R&D
Read our blogs by Grand View Research: http://www.grandviewresearch.com/blog/regenerative-medicine-market-size
Grand View Research has segmented the global regenerative
medicine market on the basis of product, therapeutic category, and region:
Regenerative Medicine Product Outlook (Revenue, USD
Million, 2014 - 2025)
- Therapeutics & Devices
- Primary Cell-bases therapeutics
- Dermatology
- Musculoskeletal
- Surgical
- Dental
- Others
- Stem Cell & Progenitor Cell-based therapeutics
- Autologous
- Allogeneic
- Others
- Tools
- Banks
- Services
Regenerative Medicine Therapeutic Category Outlook
(Revenue, USD Million, 2014 - 2025)
- Dermatology
- Musculoskeletal
- Immunology & Inflammation
- Oncology
- Cardiovascular
- Ophthalmology
- Others
Regenerative Medicine Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Middle East & Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment